Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial Katie Lew · August 29, 2024
August 29, 2024 Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical TrialGround-breaking investigational product from Melodi Health is designed to reduce post-surgical infections
August 27, 2024 NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease TreatmentEXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced
August 27, 2024 Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter CoatingHorsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the
Articles, NewsFuture Forward: Global Innovation in Medical Alley Katie LewJune 11, 2024 Future Forward: Global Innovation in Medical Alley
NewsNew Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets Tyler MasonJune 11, 2024 New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets
NewsIn the Know: Healthcare News for June 10, 2024 Tyler MasonJune 7, 2024 In the Know: Healthcare News for June 10, 2024
ArticlesFor the Record with Paul Josephs, President and CEO, Lifecore Biomedical Tyler MasonJune 7, 2024 For the Record with Paul Josephs, President and CEO, Lifecore Biomedical